Global markets started the year strong as major equity indices edged higher despite the uncertainties we continue to face. In the US, Presidential candidate Joe Biden's victory was formalised by Congress, despite the unprecedented attack on the US Capitol which disrupted proceedings. The Democratic Party also solidified its power in the Senate after winning both runoff elections in Georgia, granting the party total control of both Congress and the White House. Nearing the end of his term in office, President Trump continues his crackdown on Chinese equities, reportedly adding Chinese tech giants into its ban list; while the NYSE went back and forth on its decision to delist 3 Chinese telcos. Locally, the rapid spread of the virus across the country wore down sentiment as investors turned back to the healthcare sector as the nation awaits for the government's latest update on measures to combat the pandemic. Gold prices rose marginally on the back of a weaker US dollar, coupled with prevailing uncertainties across the globe.
In the News
- Last week, the unprecedented storm into the US capitol as lawmakers met to certify Democrat candidate Joe Biden’s victory in the US elections dominated headlines worldwide, resulted in 5 deaths, and left dozens hospitalised.
- However, markets seemed to largely ignore the extraordinary event, as the optimism of a significantly larger stimulus aid boosted market sentiment last week, as the Democrat’s win in both of the Georgia runoff elections solidified the party’s unified control of the government.
- Despite the political uncertainties that unfolded throughout the week, US markets continued to reach new highs, with the S&P 500 gaining 2.07% in MYR terms throughout the week, while the tech-focused Nasdaq outperformed the boarder market to gain 2.68%.
- Electric vehicle (EV) makers stole the limelight last week, as Tesla’s share price rallied sharply, making its founder, Elon Musk the richest person in the world; while Baidu announced its agreement with carmaker Geely Auto to produce EVs for the Chinese market. Alibaba also announced its joint venture with the China’s largest automaker SAIC motor to produce EVs, while Apple is rumoured to be in early discussions with Hyundai to produce a self-driving EV.
- The NYSE FANG Index, which tracks 10 of the most renown tech names listed in the US including those mentioned above, outperformed its peers, rising 3.02% in MYR terms. The 0830EA, which aims to provide 2X the daily performance of the said index saw rose 5.46% last week, adding onto its 168% gains in 2020. The strong performance of its underlying names pushed the ETF’s stock price to its all-time high when its NAV closed on Friday at RM12.85 per unit.
- Tensions between the US and China intensified as President Trump approaches his final days in office, as the crackdown on Chinese equities continued with reports that Alibaba and Tencent was to be included in the US’ stock ban list as it also considers banning China based apps like Alipay, Wechat Pay and others.
- The NYSE also contributed to the uncertain fate of Chinese stocks listed in the US, as the exchange went back on its decision to delist 3 Chinese telco’s; China Mobile, China Unicom and China Telecom, only to revert back to its decision by the end of the week.
- However, the Chinese market once again proved its resiliency as the CSI300 and the Shanghai Composite Index rose by 6.57% and 3.88% respectively in MYR terms last week, as China showed pushback against US’ sanctions by issuing orders that its companies need not comply with foreign restrictions, allowing its citizens and companies to sue for compensations for damaged interests.
- The New China Economy Index (gauged by the S&P New China Sectors Ex A Share Index) also ended the week in the green, upping 5.26% in MYR terms. The 0829EA, which tracks the Index ended the week with at a record high NAV of RM8.6109 after enjoy more than 5% gains over last week.
- In local markets, the raging spread of the virus throughout the country dominated market sentiment, as the pending announcement from the government regarding renewed measures on the current Movement Control Order (MCO) saw rotation back into the healthcare sector.
- With the rotation from recovery stocks into healthcare names, the 0836EA underperformed the market, sliding 2.84% as investors moved out from recovery names, while the broader KLCI gained 0.37%, supported by sharp gains in glove heavyweights.
- However, long term recovery theme is still detected across the Asia ex Japan region, as the MSCI AC Asia ex Japan IMI / EQ REITs HDY Tilt Cap, which comprises high yielding quality REITs saw gains of 1.39% , while the 0837EA upped 1.07% throughout the week.
- Despite the rally in equities globally, Gold prices rose marginally as uncertainties that have continued to hover over global economies prevailed, coupled with the weaker dollar, pushing the LBMA Gold Price Index 0.25% higher in MYR terms to end at USD 1,891.30/oz. Meanwhile, the 0828EA also saw marginal gains of 0.25% throughout the week in MYR terms.
On the Economic Data Front
- World Bank cuts global economic growth forecast:
- January 2021 Global Economic Prospect report forecast economic growth of 4% from the previous target of 4.2% growth.
- GDP growth targets were lowered for approximately half of global economies; the U.S. GDP is expected to be 3.5%, the eurozone GDP 3.6%, while China’s economy could expand 8%.
- US economic data shows mixed recovery:
- The Institute for Supply Management (ISM) announced that manufacturing PMI rose to its highest level since August 2018, at 60.7.
- ISM’s gauge for service PMI also beat expectations, hitting 57.2 to its highest level in three months.
- Labour market data surprised on the downside, as a drop of 140,000 jobs were recorded, compared to the predicted gain of 50,000 jobs.
- Eurozone data shows continued deflation:
- Eurozone consumer prices dipped 0.3% y-o-y, suffering from its 5th straight month of declines.
- Germany may see economic expansion in 4Q2020, as industrial output rose by 0.9% in November, beating expectations, while imports, exports and factory orders also beat consensus, rising 2.2%, 4.7% and 2.3% respectively.
ETF strategies at TradePlus
A look at the performance of the TradePlus ETFs, and major global indices
Learn more about TradePlus ETFs
Disclaimer: This article has been prepared by Affin Hwang Asset Management Berhad (hereinafter referred to as “Affin Hwang AM”) specific for its use, a specific target audience, and for discussion purposes only. All information contained within this presentation belongs to Affin Hwang AM and may not be copied, distributed or otherwise disseminated in whole or in part without written consent of Affin Hwang AM. The information contained in this presentation may include, but is not limited to opinions, analysis, forecasts, projections and expectations (collectively referred to as “Opinions”). Such information has been obtained from various sources including those in the public domain, are merely expressions of belief. Although this presentation has been prepared on the basis of information and/or Opinions that are believed to be correct at the time the presentation was prepared, Affin Hwang AM makes no expressed or implied warranty as to the accuracy and completeness of any such information and/or Opinions. As with any forms of financial products, the financial product mentioned herein (if any) carries with it various risks. Although attempts have been made to disclose all possible risks involved, the financial product may still be subject to inherent risk that may arise beyond our reasonable contemplation. The financial product may be wholly unsuited for you, if you are adverse to the risk arising out of and/or in connection with the financial product. Affin Hwang AM is not acting as an advisor or agent to any person to whom this presentation is directed. Such persons must make their own independent assessments of the contents of this presentation, should not treat such content as advice relating to legal, accounting, taxation or investment matters and should consult their own advisers. Affin Hwang AM and its affiliates may act as a principal and agent in any transaction contemplated by this presentation, or any other transaction connected with any such transaction, and may as a result earn brokerage, commission or other income. Nothing in this presentation is intended to be, or should be construed as an offer to buy or sell, or invitation to subscribe for, any securities. Neither Affin Hwang AM nor any of its directors, employees or representatives are to have any liability (including liability to any person by reason of negligence or negligent misstatement) from any statement, opinion, information or matter (expressed or implied) arising out of, contained in or derived from or any omission from this presentation, except liability under statute that cannot be excluded.
Warning Statement: A copy of the Prospectus / Supplemental Prospectus for the TradePlus Shariah Gold Tracker and TradePlus S&P New China Tracker, the Prospectus for the TradePlus DWA Malaysia Momentum Tracker and TradePlus MSCI Asia Ex Japan REITs Tracker, as well as the Master Prospectus for the TradePlus NYSE® FANG+™ Daily (2x) Leveraged Tracker, TradePlus NYSE® FANG+™ Daily (-1x) Inverse Tracker, TradePlus HSCEI Daily (2x) Leveraged Tracker and TradePlus HSCEI Daily (-1x) Inverse Tracker (collectively known as the “TradePlus L&I ETFs”) can be obtained at Affin Hwang Asset Management's (“Affin Hwang AM”) website at www.tradeplus.com.my. Investors are advised to read and understand the contents of the Prospectus dated 28 November 2017 and Supplemental Prospectus dated 2 July 2019 (for TradePlus Shariah Gold Tracker), Prospectus dated 15 January 2019 and Supplemental Prospectus dated 2 July 2019 (for TradePlus S&P New China Tracker), Prospectus dated 9 July 2020 (for TradePlus DWA Malaysia Momentum Tracker), Prospectus dated 9 July 2020 (for TradePlus MSCI Asia Ex Japan REITs Tracker), as well as the Master Prospectus dated 26 November 2019 (for the TradePlus L&I ETFs) before investing. There are fees and charges involved when investing in the funds stated herein. Investors are advised to consider and compare the fees and charges as well of the risks carefully before investing. Investors should make their own assessment of the risks involved in investing and should seek professional advice, where necessary. The price of units and distribution payable, if any, may go down as well as up and past performance of the funds should not be taken as indicative of their future performance. The Securities Commission Malaysia has not reviewed this material and takes no responsibility for the contents of this material and expressly disclaims all liability, however arising from this material.
You may refer to the relevant Licensing Disclosure Statement & Conditions at the respective webpages for each fund available on www.tradeplus.com.my.